Marex Spectron, a global commodities broker, announced this Wednesday that it has appointed Carla Stent, who has sat on the company’s board for four years, as Non-Executive Chair of the Group Board.
Until recently, Stent was the Chair of Marex Spectron’s Audit & Compliance Committee. She is replacing Simon Heale, who stood down in December after three years in the position.
Carla Stent’s Career History
During her career, Stent has gathered experience both in executive and non-executive roles across financial services. Principally, these roles have been in banking and private equity, however, she has also dabbled in retail and travel.
Currently, Stent is on the Board of Post Office Limited, JP Morgan Elect plc, Savernake Capital Group, and Power to Change. Previously she has also served on the Boards of Change Alliance (India) Private Limited, Christian Aid, The Young Women’s Trust, and Virgin Group and more.
Introducing Trader's Room v3 by B2BrokerGo to article >>
Commenting on her new position, Carla Stent said: “I am delighted to have been appointed Chair of Marex Spectron. This is an exciting time for the company, with a number of recent acquisitions and new developments, and I look forward to closely working with Ian Lowitt and the Board to continue on this upwards trajectory.”
For three years from 2010 until 2016, Stent was the Chief Operating Officer (COO) and Partner at Virgin Group. Before this, she was employed ar the Global Retail and Commercial Bank arm of Barclays Bank, where she was the Deputy Chief Financial Officer and Chief Administrative Officer.
Prior to this, from 2000 until 2004, she held a number of positions at Thomas Cook AG Group. This includes Operations Director and Director of Group Strategy & Corporate Finance, the statement said.
“To have someone of Carla’s calibre as Chair of Marex Spectron is a wonderful outcome for the firm. After four years on the Board she has a tremendous understanding of Marex Spectron and brings great experience to this role,” added Jeremy Isaacs of JRJ Group.